Dengue antibodies for lateral-flow applications

Dengue virus is endemic in tropical countries worldwide. Mosquito-borne, the infection manifests as dengue fever, but can progress to more serious conditions including haemorrhagic fever. There are four serotypes of the virus and all are capable of causing disease. A non-structural glycoprotein (NS1) is produced during acute infection and can be found at high levels in patient serum.

ViroStat has now released several new monoclonal antibodies to the NS1 glycoprotein of the virus that recognise the NS1 protein of all four dengue serotypes. These antibodies have recently been validated for rapid lateral-flow immunoassay detection methods.

www.virostatinc.com

 

Other news

Meeting of Minds

Upcoming Events

UK NEQAS for Blood Coagulation: Providing an Anticoagulant Service

The Principal York Hotel, Station Road, York YO24 1AA
22 September 2017

IBMS Biomedical Science Congress

ICC, Birmingham
24-27 September 2017

UK NEQAS: Coordinating Point-of-Care Testing

Queen Elizabeth II Conference Centre, Broad Sanctuary, Westminster, London SW1 3EE
20 October 2017

British Association for Cytopathology

National Railway Museum, York
4 November 2017

Biosafety Practitioner Level 1 Training Course

Public Health England
15-19 January 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2017

Screening for haemoglobinopathies

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.